With a successful demonstration of a proof-of-concept device at Knowledge for Growth (#KFG2023) before the summer holiday period, BioDevice-CRO is gaining momentum. Antleron Co-Development Architect, Filip Donvil, and ICsense CEO Bram de Muer, were interviewed by BioVox, for the MEDVIA article series, to talk about the motivations and vision behind the collaborative project and offering.
You can read the full article here -> https://lnkd.in/ePACuaRn
The BioDevice-CRO partnership, powered by MEDVIA, provides actors with customizable, modular bioprocess solutions. Combining the multidisciplinary expertise of Antleron, Comate, and ICsense brings a unique offering to life science organizations.
Links to the eco-system: